Herz-Kreislauf-Erkrankungen (Kardiologie)

Analysis of Congenital Heart Diseases Market

Introduction
Congenital heart disease (COHD) is a heart condition resulting from an abnormality in heart structure or function that is present at birth. Some common congenital heart defects include Atrial Septal Defect (ASD), Ventricular Septal Defect (VSD), Patent Foramen Ovale (PFO), Left Atrial Appendage (LAA) and Patent Ductus Arteriosus (PDA). Ventricular Septal Defects (VSD) is the most common type of congenital heart defects... mehr

France Cardiovascular Devices Market Outlook to 2016

France Cardiovascular Devices Market Outlook to 2016

Summary

GlobalData’s medical device report offering, 'France Cardiovascular Devices Market Outlook to 2016” provides key market data on the France cardiovascular devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within seven market categories — Interventional Cardiology, Per... mehr

Italy Cardiovascular Devices Market Outlook to 2016

Italy Cardiovascular Devices Market Outlook to 2016

Summary

GlobalData’s medical device report offering, 'Italy Cardiovascular Devices Market Outlook to 2016” provides key market data on the Italy cardiovascular devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within seven market categories — Interventional Cardiology, Periph... mehr

Australia Cardiovascular Devices Market Outlook to 2016

Australia Cardiovascular Devices Market Outlook to 2016

Summary

GlobalData’s medical device report offering, 'Australia Cardiovascular Devices Market Outlook to 2016” provides key market data on the Australia cardiovascular devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within seven market categories — Interventional Cardio... mehr

Argentina Cardiovascular Devices Market Outlook to 2016

Argentina Cardiovascular Devices Market Outlook to 2016

Summary

GlobalData’s medical device report offering, 'Argentina Cardiovascular Devices Market Outlook to 2016” provides key market data on the Argentina cardiovascular devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within seven market categories — Interventional Cardio... mehr

Republic of Korea Cardiovascular Devices Market Outlook to 2016

Republic of Korea Cardiovascular Devices Market Outlook to 2016

Summary

GlobalData’s medical device report offering, 'Republic of Korea Cardiovascular Devices Market Outlook to 2016” provides key market data on the Republic of Korea cardiovascular devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within seven market categories &mdas... mehr

Taiwan Cardiovascular Devices Market Outlook to 2016

Taiwan Cardiovascular Devices Market Outlook to 2016

Summary

GlobalData’s medical device report offering, 'Taiwan Cardiovascular Devices Market Outlook to 2016” provides key market data on the Taiwan cardiovascular devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within seven market categories — Interventional Cardiology, Per... mehr

India Cardiovascular Devices Market Outlook to 2016

India Cardiovascular Devices Market Outlook to 2016

Summary

GlobalData’s medical device report offering, 'India Cardiovascular Devices Market Outlook to 2016” provides key market data on the India cardiovascular devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within seven market categories — Interventional Cardiology, Periph... mehr

China Cardiovascular Devices Market Outlook to 2016

China Cardiovascular Devices Market Outlook to 2016

Summary

GlobalData’s medical device report offering, 'China Cardiovascular Devices Market Outlook to 2016” provides key market data on the China cardiovascular devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within seven market categories — Interventional Cardiology, Periph... mehr

Spain Cardiovascular Devices Market Outlook to 2016

Spain Cardiovascular Devices Market Outlook to 2016

Summary

GlobalData’s new report, 'Spain Cardiovascular Devices Market Outlook to 2016” provides key market data on the Spain cardiovascular devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within seven market categories — Interventional Cardiology, Peripheral Vascular Device... mehr

Netherlands Cardiovascular Devices Market Outlook to 2016

Netherlands Cardiovascular Devices Market Outlook to 2016

Summary

GlobalData’s new report, 'Netherlands Cardiovascular Devices Market Outlook to 2016” provides key market data on the Netherlands cardiovascular devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within seven market categories — Interventional Cardiology, Peripher... mehr

Belgium Cardiovascular Devices Market Outlook to 2016

Belgium Cardiovascular Devices Market Outlook to 2016

Summary

GlobalData’s new report, 'Belgium Cardiovascular Devices Market Outlook to 2016” provides key market data on the Belgium cardiovascular devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within seven market categories — Interventional Cardiology, Peripheral Vascular ... mehr

United Kingdom Cardiovascular Devices Market Outlook to 2016

United Kingdom Cardiovascular Devices Market Outlook to 2016

Summary

GlobalData’s new report, 'The UK Cardiovascular Devices Market Outlook to 2016” provides key market data on the United Kingdom cardiovascular devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within seven market categories — Interventional Cardiology, Periphe... mehr

Japan Cardiovascular Devices Market Outlook to 2016

Japan Cardiovascular Devices Market Outlook to 2016

Summary

GlobalData’s new report, 'Japan Cardiovascular Devices Market Outlook to 2016” provides key market data on the Japan cardiovascular devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within seven market categories — Interventional Cardiology, Peripheral Vascular Device... mehr

United States Cardiovascular Devices Market Outlook to 2016

United States Cardiovascular Devices Market Outlook to 2016

Summary

GlobalData’s new report, 'US Cardiovascular Devices Market Outlook to 2016” provides key market data on the US cardiovascular devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within seven market categories — Interventional Cardiology, Peripheral Vascular Devi... mehr

Germany Cardiovascular Devices Market Outlook to 2016

Germany Cardiovascular Devices Market Outlook to 2016

Summary

GlobalData’s new report, 'Germany Cardiovascular Devices Market Outlook to 2016” provides key market data on the Germany cardiovascular devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within seven market categories — Interventional Cardiology, Peripheral Vascular ... mehr

Cough, Cold and Allergy (Hay Fever) Remedies - Malaysia

As the influenza A (H1N1) virus spread across the world during 2009, Malaysia detected the first case of influenza A (H1N1) virus in May 2009. The signs and symptoms of influenza A (H1N1) flu virus included a cough and a sore throat. As a result, consumers became extra cautious with regard to their health and preferred to consult a doctor as a safety precaution, rather than self-medicate for flu and cough.

Euromonitor Interna... mehr

Acute Coronary Syndromes Therapy Area Pipeline Report

Life Science Analytics', Acute Coronary Syndromes Therapy Area Pipeline Report contains detailed information on the acute coronary syndromes drug pipeline. This report provides insight into the pipeline status of acute coronary syndromes drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report ... mehr

Atrial Fibrillation Therapy Area Pipeline Report

Life Science Analytics', Atrial Fibrillation Therapy Area Pipeline Report contains detailed information on the atrial fibrillation drug pipeline. This report provides insight into the pipeline status of atrial fibrillation drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the us... mehr

Congestive Heart Failure Therapy Area Pipeline Report

Life Science Analytics', Congestive Heart Failure Therapy Area Pipeline Report contains detailed information on the congestive heart failure drug pipeline. This report provides insight into the pipeline status of congestive heart failure drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report ... mehr

Coronary Artery Disease Therapy Area Pipeline Report

Life Science Analytics', Coronary Artery Disease Therapy Area Pipeline Report contains detailed information on the coronary artery disease drug pipeline. This report provides insight into the pipeline status of coronary artery disease drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report pro... mehr

Myocardial Infarction Therapy Area Pipeline Report

Life Science Analytics', Myocardial Infarction Therapy Area Pipeline Report contains detailed information on the myocardial infarction drug pipeline. This report provides insight into the pipeline status of myocardial infarction drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides ... mehr

Stroke Therapy Area Pipeline Report

Life Science Analytics', Stroke Therapy Area Pipeline Report contains detailed information on the Stroke drug pipeline. This report provides insight into the pipeline status of Stroke drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real detail on drug pipelines, ... mehr

The Future of Cardiovascular Diagnostics: Impact of technological advances on growth opportunities and future market outlook

Cardiovascular disease (CVD) is one of the leading causes of death in the developed world, accounting for around a third of all deaths. It remains a tremendous medical and cost burden on society. The identification and application of novel cardio biomarkers has helped cardiologists to stratify high risk patients whilst the advances in diagnostic imaging has lead to improvements in the speed and resolution of images, increasing its clini... mehr

Acute Heart Failure - Drug Pipeline Analysis and Market Forecasts to 2016

Acute Heart Failure - Drug Pipeline Analysis and Market Forecasts to 2016

Summary

GlobalData, the industry analysis specialist’s new report, 'Acute Heart Failure — Drug Pipeline Analysis and Market Forecasts to 2016” is an essential source of information and analysis on the global acute heart failure market. The report identifies the key trends shaping and driving the global acute heart failure market. The re... mehr

Atherosclerosis Or Coronary Artery Disease (CAD) - Drug Pipeline Analysis and Market Forecasts to 2016

Atherosclerosis Or Coronary Artery Disease (CAD) - Drug Pipeline Analysis and Market Forecasts to 2016

Summary

GlobalData, the industry analysis specialist’s new report, 'Atherosclerosis Or Coronary Artery Disease (CAD) — Drug Pipeline Analysis and Market Forecasts to 2016” is an essential source of information and analysis on the global atherosclerosis market. The report identifies the key trends shaping and... mehr

Stakeholder Opinions: Fixed dose combinations in the cardiovascular and metabolic diseases - From life cycle management to franchise core

Introduction

Datamonitor expects the fixed dose combination market to reach $19 billion, across the seven major markets, by 2018. Patent expiries in the key primary care markets are forcing Pharma companies to consider life-cycle management strategies to protect brand sales. Fixed-dose combinations offer an attractive means of protecting and enhancing at-risk franchises.

Scope

*Analysis of fixed-dose com... mehr

Stakeholder Opinions: Fixed dose combinations in the cardiovascular and metabolic diseases - From life cycle management to franchise core

Introduction

Datamonitor expects the fixed dose combination market to reach $19 billion, across the seven major markets, by 2018. Patent expiries in the key primary care markets are forcing Pharma companies to consider life-cycle management strategies to protect brand sales. Fixed-dose combinations offer an attractive means of protecting and enhancing at-risk franchises.

Scope

*Analysis of fixed-dose com... mehr

Atrial Fibrillation - Drug Pipeline Analysis and Market Forecasts to 2016

Atrial Fibrillation - Drug Pipeline Analysis and Market Forecasts to 2016

Summary

GlobalData, the industry analysis specialist's new report, 'Atrial Fibrillation — Drug Pipeline Analysis and Market Forecasts to 2016 is an essential source of information and analysis on the global atrial fibrillation therapeutics market, a key segment within the pharmaceutical and healthcare industry. This pharma report identi... mehr

Acute Coronary Syndrome - Drug Pipeline Analysis and Market Forecasts to 2016

Acute Coronary Syndrome - Drug Pipeline Analysis and Market Forecasts to 2016

Summary

GlobalData, the industry analysis specialist's new report, 'Acute Coronary Syndrome - Drug Pipeline Analysis and Market Forecasts to 2016 is an essential source of information and analysis on the global acute coronary syndrome market. The report identifies the key trends shaping and driving the global acute coronary syndrome marke... mehr

The Cardiovascular Market Outlook to 2014: Competitive landscape, global market analysis and pipeline analysis

The Cardiovascular Market Outlook to 2014 provides comprehensive coverage of the cardiovascular market, incorporating a disease overview and detailed epidemiological analyses of the major indications. This report makes a wide-ranging assessment of the marketed product portfolio, R&D pipeline, market share data, sales forecast and competitive landscape for the major players. Furthermore, it highlights the key market and R&D trend... mehr

Anti-hypertension - Drug Pipeline Analysis and Market Forecasts to 2016

Anti-hypertension - Drug Pipeline Analysis and Market Forecasts to 2016

Summary

GlobalData, the industry analysis specialist’s new report, 'Anti-Hypertension - Drug Pipeline Analysis and Market Forecasts to 2016' is an essential source of information and analysis on the global anti-hypertension market, a key segment within the pharmaceutical and healthcare industry. This pharma report identifies the key trends shap... mehr

Global Cardiovascular Devices Market 2008-2012

The cardiovascular devices represent one of the major markets in the medical equipment industry. This market consists of Cardiac Rhythm Management (CRM) devices, Interventional Cardiology (IC) devices, cardiovascular prosthetic devices, and cardiovascular surgery.
With the advancement in technology, better therapies and solutions have been introduced into the healthcare market. Further, due to the intense competition, the players ... mehr

Global Heart Valve Market 2008-2012

The growth in the aging population (generally 60 and above) is one of the major of drivers for the healthcare industry. This section is also one of the major contributors to the revenues in the healthcare industry. It is estimated that by 2010, more than 45 million people in the US will be more than 65 years. China, France, Japan and the other major countries are also going to witness an increased percentage of aged populations. The dem... mehr

Global Implantable Cardioverter Defibrillator (ICD) Market 2008-2012

The ageing population, coupled with the increasing cases of cardiovascular diseases, and advancement in new innovative technologies, are driving the growth of Implantable Cardioverter Defibrillator (ICD) devices. ICDs are widely being used in Americas and Europe. Further, expansion of ICD therapies across the different Asian countries like China, Japan and India holds a potential growth for the ICD market.
Consolidation of the indu... mehr

Commercial Insight: Cardiovascular and metabolic market overview Innovative development pipeline provides limited growth as primary care markets become generic

Introduction

Datamonitor expects antidiabetic therapies to emerge as the biggest revenue earner in the cardiovascular and metabolic markets by 2018. A large and diverse development pipeline will provide a number of new blockbuster drugs but the heavy genericization of the hypertension and dyslipidemia primary care markets will lead to the overall market only growing by 0.9% in the seven major markets.

Scope
mehr

Global Cardiac Rhythm Management (CRM) Market 2008-2012

Cardiac Rhythm Management (CRM) is a field of treatment in cardiology. It involves various therapies in administering cardiac arrhythmias (abnormal electrical activity in the heart). CRM majorly consists of devices such as Implantable Cardioverter Defibrillators (ICD), implantable pacemakers, and other CRM monitoring devices.
In early 2000’s, the CRM market experienced several product warnings and recalls, pertaining to quality con... mehr

Forecast Insight: Dyslipidemia - While the market collapses, a well designed clinical trial program pays dividends for Crestor

Introduction

The antidyslipidemic market is expected to fall to $18 billion in 2018. The decline will be driven by the deep genericization of the market, further exacerbated by the patent expiry of the top antidyslipidemic, Pfizer's Lipitor, as well as by the recent negative messages from the ENHANCE, SEAS and ARBITER 6 HALTS clinical trials.

Scope

*Description of the competitive landscape in antidyslipi... mehr

The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis

The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis

Summary

GBI Research, the leading business intelligence provider, has released its latest research “The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis.” The report provides in... mehr

Forecast Insight: Antihypertensives New fixed dose combinations unable to stem the tide of patent expiries

Introduction

Following the patent expiries of ARBs Datamonitor expects antihypertensives sales in the seven major markets to record sales of $29.5 billion in 2018, a drop of over $6 billion compared to 2008. With no promising novel pipeline agents, pharmaceutical companies have little choice but to adopt line extension life cycle management strategies introducing a number of new fixed dose combinations.

Scope
... mehr

Global Cardiac Rhythm Management (CRM) Market Report: 2009 Edition

The increasing number of cardiovascular diseases and sudden cardiac deaths are driving the growth of cardiac rhythm management devices market. The CRM market broadly consists of implantable cardioverter-defibrillators (ICD) and pacemakers.

The CRM market registered double digit growth rates in early 90s but several product recalls during early 2000s led to a significant decline in the utilization of ICDs. However, the CRM mar... mehr

Global Coronary Stent Market Report

Heart diseases or heart attacks are nowadays becoming more and more common, and in fact, are one of the largest killing diseases worldwide. Heart attack is caused by narrowing of or any blockage in the coronary arteries, which supply blood to heart muscles. Stents used in the coronary arteries to keep them open are called coronary stents, and due to intensity and the rate of increase in the disease are also gaining importance.

mehr

Intravascular Ultrasound (IVUS) Market: An Analysis

IVUS market is the fastest growing segment of interventional cardiology. IVUS is primarily used during the stenting procedure in the percutaneous coronary intervention (PCI). The growth in this market is mainly based on the number of PCI procedures and stenting procedures or the stenting placements. More the stents being used, more would be the need of IVUS technology.

IVUS technology is used to properly observe the placement... mehr

Worldwide Heart Valve Market Report: 2009 Edition

The two major segments of heart valve market — tissue valve & mechanical valve — both have pros and cons. Tissue valves have a lower risk for clotting but they are not durable for long-term usage compared to mechanical valves. Mechanical valves are more durable, but require anti-coagulant drugs to prevent blood clots. Tissue valve are ideal for older patients.

The mechanical valve market is expected to continu... mehr

Stakeholder Opinions: Commercial strategies in cardiovascular and metabolic diseases successful market positioning at company and brand level becomes paramount

Introduction

Datamonitor expects commercial strategies in the cardiovascular and metabolic markets to become increasingly important as the markets mature. The report details strategies used by pharmaceutical companies to capture market share, to differentiate brands from the competition, for revenue maximization and for the defense of brand revenues from generic competition.

Scope

*Analysis of company an... mehr

Opportunities in Heart Health: Consumer Attitudes & Behaviors

Introduction

Growing interest in heart health products reflects the broader demand for functional food and drinks. Consumers are generally aware of the importance of maintaining good cardiovascular health and that something needs to be done in order to reverse the increase in related health problems such as diabetes. However, inhibitors such as trust issues regarding functional products still remain.

Scope
mehr

Stakeholder Opinions: Pulmonary Arterial Hypertension clinical community builds order from chaos

Introduction

Despite an explosion in the number of drugs and treatment strategies available, pulmonary arterial hypertension is still a rapidly fatal condition for a small, hard to identify patient group. A small clinical elite is currently leading the way in advancing treatment outcomes, and is central to determining which new treatment strategies are used.

Scope

*Defining the key clinical characteristi... mehr

The Asian Cardiovascular Market Outlook to 2014: Regional and therapeutic analysis, pipeline impact and growth opportunities

The Asian Cardiovascular Market Outlook to 2013
Regional and therapeutic analysis, pipeline impact and growth opportunities

Report Overview

The Asian cardiovascular market continues to grow at significant pace, having registered growth of 19.9% over 2006/07. This is in stark contrast to the global cardiovascular market, where the patent expiries of leading products and subsequent generic competition has slowed... mehr

Commercial Insight: Cardiovascular and metabolic market overview Diabetes to the fore as generics hit primary care markets

Introduction

Datamonitor expects antidiabetic therapies to emerge as the biggest revenue earner in the cardiovascular and metabolic markets by 2017. A large and diverse development pipeline will provide a number of new blockbuster drugs but the heavy genericization of the hypertension and dyslipidemia primary care markets will lead to the overall market only growing by 0.9% in the seven major markets.

Scope
mehr

Commercial Insight: Cardiovascular and metabolic market overview Diabetes to the fore as generics hit primary care markets

Introduction

Datamonitor expects antidiabetic therapies to emerge as the biggest revenue earner in the cardiovascular and metabolic markets by 2017. A large and diverse development pipeline will provide a number of new blockbuster drugs but the heavy genericization of the hypertension and dyslipidemia primary care markets will lead to the overall market only growing by 0.9% in the seven major markets.

Scope
mehr

The Cardiovascular Market Outlook to 2013: Competitive landscape, global market analysis and pipeline analysis

The cardiovascular therapy area spans a range of treatment classes including anti-hypertensives, anti-dyslipidemics, anti-thrombotics, hematological preparations and cardiac therapies. Each sub-therapy area is facing a different set of issues and challenges, such as the current generic threat for dyslipidemics and competition from novel therapies in thrombosis. Leading products in these sub-therapy areas have proven to be significant gr... mehr

Stakeholder Insight: Acute Coronary Syndromes ACS in Europe, what is the best practice?

Introduction

The face of ACS continues to change. The ageing population and pressure of growing risk factors have made a significant impact on the management strategies in ACS. This report extends the previous year report and unveils the true picture through in-depth analysis of data on over 29,000 ACS patient records in the 5 major European pharmaceutical markets (France, Germany, Italy, Spain and the UK).

Scope mehr

Worldwide Heart Valve Market: Focus on Tissue Valves

Cardiovascular diseases, particularly heart attacks and strokes, cause the death of about seventeen million people worldwide annually. In the US alone, around five million people suffer from heart problems.

In heart valve market, mechanical valves are more durable than tissue heart valves but require an anticoagulant. With technological advancements, the issue of durability has been resolved and hence, the market has moved to... mehr

Blood and Lymphatic System Electrolyte Deficiencies

Life Science Analytics', 'Blood and Lymphatic System Electrolyte Deficiencies ' contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real deta... mehr

Blood and Lymphatic System Hemophilia or Blood Coagulation Disorders

Life Science Analytics', 'Blood and Lymphatic System Hemophilia or Blood Coagulation Disorders ' contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the us... mehr

Blood and Lymphatic System Hemorrhage

Life Science Analytics', 'Blood and Lymphatic System Hemorrhage ' contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real detail on drug pipe... mehr

Blood and Lymphatic System Thromboembolism

Life Science Analytics', 'Blood and Lymphatic System Thromboembolism ' contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real detail on dru... mehr

Cardiovascular and Circulatory System Acute Coronary Syndromes

Life Science Analytics', 'Cardiovascular and Circulatory System Acute Coronary Syndromes ' contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the user wit... mehr

Cardiovascular and Circulatory System Angina

Life Science Analytics', 'Cardiovascular and Circulatory System Angina ' contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real detail on d... mehr

Cardiovascular and Circulatory System Arrhythmiasis

Life Science Analytics', 'Cardiovascular and Circulatory System Arrhythmiasis ' contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real deta... mehr

Cardiovascular and Circulatory System Atherosclerosis or Coronary Artery Disease

Life Science Analytics', 'Cardiovascular and Circulatory System Atherosclerosis or Coronary Artery Disease ' contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report pro... mehr

Cardiovascular and Circulatory System Congestive Heart Failure

Life Science Analytics', 'Cardiovascular and Circulatory System Congestive Heart Failure ' contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the user wit... mehr

Cardiovascular and Circulatory System Edema

Life Science Analytics', 'Cardiovascular and Circulatory System Edema ' contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real detail on dr... mehr

Cardiovascular and Circulatory System Hypercholesterolemia

Life Science Analytics', 'Cardiovascular and Circulatory System Hypercholesterolemia ' contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with re... mehr

Cardiovascular and Circulatory System Hypertension

Life Science Analytics', 'Cardiovascular and Circulatory System Hypertension ' contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real detai... mehr

Cardiovascular and Circulatory System Intermittent Claudication

Life Science Analytics', 'Cardiovascular and Circulatory System Intermittent Claudication ' contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the user wi... mehr

Cardiovascular and Circulatory System Ischemia

Life Science Analytics', 'Cardiovascular and Circulatory System Ischemia ' contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real detail on... mehr

Cardiovascular and Circulatory System Myocardial Infarction

Life Science Analytics', 'Cardiovascular and Circulatory System Myocardial Infarction ' contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with r... mehr

Cardiovascular and Circulatory System Peripheral Vascular Disease

Life Science Analytics', 'Cardiovascular and Circulatory System Peripheral Vascular Disease ' contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the user ... mehr

Cardiovascular and Circulatory System Stroke

Life Science Analytics', 'Cardiovascular and Circulatory System Stroke ' contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real detail on d... mehr

Cardiovascular and Circulatory System Thrombosis

Life Science Analytics', 'Cardiovascular and Circulatory System Thrombosis ' contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real detail ... mehr

Kidneys and Genito-Urinary System Hyperphosphatemia

Life Science Analytics', 'Kidneys and Genito-Urinary System Hyperphosphatemia ' contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real deta... mehr

Metabolic Endocrinology Hypercalcemia

Life Science Analytics', 'Metabolic Endocrinology Hypercalcemia ' contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real detail on drug pip... mehr

Metabolic Endocrinology Hypocalcemia

Life Science Analytics', 'Metabolic Endocrinology Hypocalcemia ' contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real detail on drug pipe... mehr

Stakeholder Opinions: Heart Failure - When drugs do not work

Introduction
Advanced heart failure is a growing issue. Existing pharmacological strategies increase the survival rates of acute heart failure patients, providing a growing source of patients with advanced disease. In view of long waiting lists for heart transplantation and the growing lack of donors, cardiac resynchronization and mechanical circulatory support devices have demonstrated promising results.

Scope
What... mehr

The Cardiovascular Disorders Market Outlook to 2012

The Cardiovascular Disorders Market Outlook to 2012

Business Intelligence for the Pharmaceutical Industry
Business Insights' portfolio of healthcare management reports are designed to help you make well informed and timely business decisions. We understand the problems facing today's pharmaceutical and healthcare executives when trying to drive your business forward, and appreciate the importance of accurate, up-to-date,... mehr

Global Cardiac Rhythm Management Market: ICDs and Emerging Markets to Drive Growth

Market demand, innovative products, government regulations and reimbursement policies are the four factors that have been changing the global healthcare industry continuously. These factors have also influenced the market for specialized medical devices - Cardiac Rhythm Management (CRM), which mainly comprises Implantable Cardiac Rhythm Devices (ICD) and Pacemakers.

ICDs constitute more than 60% of the global CRM market and ... mehr

Innovations in Cardiovascular Disease Management: Latest surgical procedures, drugs and medical devices

Despite significant advances in prevention and treatment, cardiovascular disease remains the leading cause of death in economically advanced countries. The developing world has also begun to experience a disconcerting growth in prevalence, where the insurgence of CVD has exacerbated the risk factors associated with indigenous communicable diseases. Keeping pace with epidemiological change in both the developed and developing world const... mehr

Commercial and Pipeline Insight: Fibromyalgia - Approvals legitimize condition and expose underserved patient population

Introduction

With a considerable patient potential and large medical unmet need, the untapped fibromyalgia market represents a lucrative opportunity for pharmaceutical companies. Estimated to total around $650m in 2007 in the seven major markets, Datamonitor forecasts the market to grow to over $2.4 billion in 2017.

Scope

*Analysis of clinical trial design and treatment guidelines in fibromyalgia.
<... mehr